This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen acción 2176
Ina Research Inc., a consulting company, provides non-clinical and clinical studies services primarily in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Competidores de Ina Research Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥899.00 |
| 52 Week High | JP¥900.00 |
| 52 Week Low | JP¥566.00 |
| Beta | 0 |
| 1 Month Change | 0.11% |
| 3 Month Change | 35.19% |
| 1 Year Change | 27.70% |
| 3 Year Change | 27.52% |
| 5 Year Change | 32.60% |
| Change since IPO | -73.94% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| 2176 | JP Life Sciences | Mercado JP | |
|---|---|---|---|
| 7D | 0.1% | 0.7% | 1.8% |
| 1Y | 27.7% | -39.9% | 33.5% |
Rentabilidad vs. Industria: 2176 exceeded the JP Life Sciences industry which returned 14.6% over the past year.
Rentabilidad vs. Mercado: 2176 exceeded the JP Market which returned -1.8% over the past year.
Volatilidad de los precios
| 2176 volatility | |
|---|---|
| 2176 Average Weekly Movement | 7.7% |
| Life Sciences Industry Average Movement | 6.2% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in JP Market | 8.3% |
| 10% least volatile stocks in JP Market | 2.2% |
Precio estable de las acciones: 2176's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: 2176's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of JP stocks.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1974 | n/a | Kenji Nakagawa | www.ina-research.co.jp |
Resumen de fundamentos de Ina Research Inc.
| Estadísticas fundamentales de 2176 | |
|---|---|
| Capitalización bursátil | JP¥2.69b |
| Beneficios(TTM) | JP¥141.00m |
| Ingresos (TTM) | JP¥2.43b |
0.0x
Ratio precio-beneficio (PE)0.0x
Ratio precio-ventas (PS)¿Está 2176 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 2176 | |
|---|---|
| Ingresos | JP¥2.43b |
| Coste de los ingresos | JP¥1.72b |
| Beneficio bruto | JP¥710.00m |
| Otros gastos | JP¥569.00m |
| Beneficios | JP¥141.00m |
Últimos beneficios comunicados
Mar 31, 2018
Próxima fecha de beneficios
Aug 10, 2022
| Beneficios por acción (BPA) | 0 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0.0% |
¿Cómo se ha desempeñado 2176 a largo plazo?
Ver rendimiento histórico y comparativa